Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.32 is 63% above its 5-year average of -14.30, near the high end of its 5-year range (-21.30–-5.32).
37.23% above its 12-month average of -8.47.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-05-31): -1.20.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-5.32
EARNINGS PER SHARE (EPS) AVG TTM
-8.47
EARNINGS PER SHARE (EPS) AVG 3Y
-12.67
EARNINGS PER SHARE (EPS) AVG 5Y
-14.30
EARNINGS PER SHARE (EPS) AVG 10Y
-18.07
EARNINGS PER SHARE (EPS) AVG 15Y
-14.21
EARNINGS PER SHARE (EPS) AVG 20Y
-18.74
CURRENT VS TTM AVG
+37.23%
CURRENT VS 3Y AVG
+58.03%
CURRENT VS 5Y AVG
+62.80%
CURRENT VS 10Y AVG
+70.56%
CURRENT VS 15Y AVG
+62.56%
CURRENT VS 20Y AVG
+71.60%
Lexaria Bioscience Corp.
Market Cap
$4.73M
Earnings Per Share (EPS)
-5.32
TTM Avg
-8.47
3Y Avg
-12.67
5Y Avg
-14.30
Market Cap
$4.53M
Earnings Per Share (EPS)
-6.95
TTM Avg
-22.18
3Y Avg
-69.66
5Y Avg
-91.58
Market Cap
$4.83M
Earnings Per Share (EPS)
-3.64
TTM Avg
-254.03
3Y Avg
-3442.01
5Y Avg
-5629.67
Market Cap
$4.55M
Earnings Per Share (EPS)
-4.39
TTM Avg
-44.24
3Y Avg
-644.57
5Y Avg
-610.60
Market Cap
$5.01M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.61
3Y Avg
-0.43
5Y Avg
-0.43
Market Cap
$4.43M
Earnings Per Share (EPS)
-9.39
TTM Avg
-11.95
3Y Avg
-11.32
5Y Avg
-8.88
Market Cap
$4.96M
Earnings Per Share (EPS)
N/A
TTM Avg
0.00
3Y Avg
-0.12
5Y Avg
-0.11
Market Cap
$5.11M
Earnings Per Share (EPS)
-4.53
TTM Avg
-13.96
3Y Avg
-30.40
5Y Avg
-166.98
Market Cap
$4.28M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.88
3Y Avg
-0.66
5Y Avg
-0.44
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $4.73M | -5.32 | -8.47 | -12.67 | -14.30 |
| CalciMedica, Inc. (CALC)vs › | $4.53M | -6.95 | -22.18 | -69.66 | -91.58 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | -3.64 | -254.03 | -3442.01 | -5629.67 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | -4.39 | -44.24 | -644.57 | -610.60 |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | N/A | -1.61 | -0.43 | -0.43 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.43M | -9.39 | -11.95 | -11.32 | -8.88 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.96M | N/A | 0.00 | -0.12 | -0.11 |
| Imunon, Inc. (IMNN)vs › | $5.11M | -4.53 | -13.96 | -30.40 | -166.98 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.28M | -0.76 | -0.88 | -0.66 | -0.44 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | -61.25 | -79.52 | -97.16 | -86.80 |
Trailing EPS (TTM)
$-5.32
Forward EPS (Est.)
$-4.65
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-08-31 | -9.90 |
| 2024-08-31 | -7.05 |
| 2023-08-31 | -15.15 |
| 2022-08-31 | -18.60 |
| 2021-08-31 | -13.80 |
| 2020-08-31 | -21.30 |
| 2019-08-31 | -24.30 |
| 2018-08-31 | -41.85 |
| 2017-08-31 | -14.25 |
| 2016-08-31 | -12.45 |
| 2015-08-31 | -20.10 |
| 2014-08-31 | -1.09 |
| 2012-10-31 | -6.30 |
| 2011-10-31 | -16.35 |
| 2010-10-31 | -18.30 |
| 2009-10-31 | -42.00 |
| 2008-10-31 | -66.90 |
| 2007-10-31 | -78.15 |
| 2006-10-31 | -47.40 |
| 2005-10-31 | -7.05 |
